Krebs Biochemicals and Industries share news, announcements and annual reports
NSE: KREBSBIOBSE: 524518Pharmaceuticals & BiotechnologySmall Cap
Krebs Biochemicals and Industries Limited · Formerly Krebs Biochemicals · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on NSE, May 2000 on BSE
Last close ₹54.52down ₹2.08 (3.67%)BSE ₹55.33
Share price at the NSE close on 2 Nov 2026. Previous close ₹56.60.
2 Nov: open ₹56.61, high ₹57.69, low ₹53.40
52-week range of traded prices to 2 Nov 2026
₹38.33Low, 30 Mar 2026₹76.85High, 5 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 2 Nov 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹118 Cr2,740th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- Net worth zero or below
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 28,45768.7% delivered
Krebs Biochemicals and Industries share news and announcements
498 announcements, routine notices left out, newest first. Page 9 of 10.
Aug 2014
May 2014
15 May · Extension of Financial Year
Board of Directors of the Company held on May 15, 2014 has considered : (1) To extend the accounting year of the Company till June 30, 2014. Therefore the accounting year of the company for the current year will be from July 01, 2013 to June 30, 2014.15 May · Results
9 May · Board meeting
To consider and approve the following: (1) Un-audited financial results for the 3rd quarter ended March 31, 2014 since we are closing the accounts for the financial year as on June 30, 2014 in line with the previous financial year which was closed on June 30, 2013. (2) Any other business with the permission of the Chair.
Feb 2014
13 Feb · Board meeting
Board of Directors of the companys at its meeting held on February 13, 2014 has considered : (1) To take note of the Withdrawal of Nomination of Ms. Dayachandrahas, EXIM Bank- Nominee Director. (2) Postal Ballot Notice and appointment of Scrutinizer to conduct the postal ballot process.13 Feb · Results
5 Feb · Board meeting
To consider the following : (1) Un-Audited financial results for the quarter ended December 31, 2013; and the unaudited financial results for the six months period from July 01, 2013 to December 31, 2013 .(2) Any other business with the permission of the Chair.
Dec 2013
2 Dec · Meeting
Register of members and transfer registers will remain closed from December 18, 2013 to December 21, 2013 for the purpose of Annual General Meeting to be held on December 21, 2013.
Nov 2013
5 Nov · Board meeting
To consider the following : (1) Un-Audited financial results for the quarter ended September 30, 2013; (2) Any other business with the permission of the Chair.
Aug 2013
29 Aug · Results
19 Aug · Board meeting
To consider the following: 1) Audited financial results for the quarter and year ended June 30, 2013 ( Since extension of Financial Year by 3 months taken from Registrar of Companies, Andhra Pradesh). 2) Any other business with the permission of the chair.6 Aug · Board meeting
To consider and approve the following: (1) Audited financial results for the quarter and year ended June 30, 2013; (2) Any other business with the permission of the Chair.
May 2013
15 May · Board meeting
Board of Directors of the Company at its meeting held on May 15, 2013, inter alia, has considered and approved the following: (1) Extension of financial year 2012-13 by three months, i.e. upto June 30, 2013.(2) Raising of funds by identifying strategic investor/s and authorized Mr. Avinash Ravi, Director and COO to take necessary steps in this regard.(3) Shifting of registered office of the Company from 8-2-277/A, Plot No. 130, 4A, 4th Floor, Inwinex Towers, Road No.2, Banjara Hills, Hyderabad-500034 to 8-2-577/B, Plot No. 34, Road No 8, Banjara Hills, Hyderabad - 500034.(4). Appointment of M/s. Bojanapally & Associates as the cost auditor for the financial year 2013-14.(5). Authorisation to Mr. Avinash Ravi, Director and COO to act as Compliance Officer.15 May · Extension of Financial Year
Financial year of the Company for 2012-13 has been extended by 3 months. Accordingly the financial accounts for the year 2012-13 will be closed by June 30, 2013.15 May · Management
Company Secretary of the Company Ms.A.Naga Vasudha has resigned from the office w.e.f. April 10, 2013.10 May · Board meeting
To consider and approve the following: (1) Un-audited financial results for the quarter ended March 31, 2013; (2) Any other business with the permission of the Chair.
Feb 2013
4 Feb · Board meeting
To consider and approve the un-audited financial results for the quarter ended December 31, 2012.
Nov 2012
3 Nov · Board meeting
To consider and approve the following : (1) Un-Audited financial results for the quarter ended September 30, 2012; (2) Any other business with the permission of the Chair.
Sep 2012
18 Sep · Corporate action
Share transfer books of the Company will remain closed from September 22, 2012 to September 26, 2012 (both days inclusive) for the purpose of convening annual general meeting of the Company.
Aug 2012
6 Aug · Board meeting
To consider and approve the following: (1) Un-Audited financial results for the quarter ended June 30, 2012; (2) Any other business with the permission of the Chair.
May 2012
17 May · Results
8 May · Board meeting
To consider and approve the following: (1) Audited financial results for the last quarter ended March 31, 2012; (2) Any other business with the permission of the Chair.
Feb 2012
2 Feb · Board meeting
To consider and approve the unaudited financial results for the quarter ended December 31, 2011.
Nov 2011
11 Nov · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on November 15, 2011 to consider and approve the un-audited financial results for the half year ended September 30, 2011. The Company has now informed the Exchange that the aforesaid Board Meeting has been rescheduled and will now be held on November 14, 2011.Not held on this date
4 Nov · Board meeting
To consider and approve the un-audited financial results for the half year ended September 30, 2011.
Oct 2011
Sep 2011
13 Sep · Meeting
Annual General Meeting of the Company will be held on September 29, 2011. Further the register of members and transfer registers will remaine closed from September 26, 2011 to September 29, 2011, both days inclusive for the purpose of convening Annual General Meeting of the Company.
Jul 2011
25 Jul · Board meeting
To consider and approve the Un-audited financial results for the quarter ended June 30, 2011.
May 2011
26 May · Board meeting
To consider and approve the audited financial results for the last quarter as well as financial year ended March 31, 2011.
Mar 2011
Jan 2011
28 Jan · Board meeting
Meeting of the Board of Directors of the Company scheduled to be held on January 31, 2011 stands postponed and the same will be held on February 02, 2011 to consider and approve the Un-audited financial results for the quarter ended December 31, 2010.25 Jan · Board meeting
To consider and approve the un-audited financial results for the quarter ended December 31, 2010.
Dec 2010
15 Dec · Updates
Board of Directors of the Company in their meeting held on December 10, 2010 have decided to issue 3,33,333 Equity Shares to Mr. Avinash Ravi, Existing Promoter and Chief Operating Officer of the Company on preferential basis at the price calculated in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009. The said shares are being issued to the promoter in accordance with the CDR package sanctioned by the lenders. Further the Board of Directors have decided to obtain the approval of members of the Company, for the proposed preferential issue, by way of postal ballot. The Board had appointed Mr. D. S. M. Ram, Proprietor of DSMR & Associates, Company Secretaries as scrutinizer for conducting the postal ballot.
Nov 2010
Oct 2010
25 Oct · Board meeting
To consider and approve the un-audited financial results for the quarter ended September 30, 2010.18 Oct · Management
New Company Secretary Ms. Naga Vasudha appointed by the Board of Directors of the Company will act as Compliance Officer of the Company.
Sep 2010
17 Sep · Meeting
Aug 2010
17 Aug · Meeting
Members of the Company at the Annual General Meeting held on August 16, 2010, inter alia, had: (1) Adopted and approved the Balance Sheet for the year ended March 31, 2010 and the Profit and Loss Account as on that date along with the relevant schedules and the Directors Report and Auditors Report thereon (2) Approved the re appointment of Mr. Avinash Ravi as Director liable to retire by rotation (3) Approved the re-appointment of Dr. T.Kuchroo as Director liable to retire by rotation (4) Approved the appointment of M/s.Pavuluri & Co, Chartered Accountants as Statutory Auditors of the Company to hold office from the conclusion of this Annual General Meeting till the conclusion of the next Annual General Meeting.12 Aug · Meeting
Register of Members and Share Transfer Books of the Company will remain closed on August 18, 2010 (only one working day) in connection with the Annual General Meeting to be held on August 16, 2010.
Jul 2010
13 Jul · Board meeting
Inter alia to consider and take on record unaudited financial results for the first quarter ended June 30, 2010 of the year 2010-11.
Jun 2010
11 Jun · Updates
Office of the Company Secretary became vacant wef May 24, 2010 due to his resignation. For the time being and until new Company Secretary appointment Sri Avinash Ravi, Director and COO of the Company will act as Compliance Officer of the Company